Stocks Industrials BRKRP
NASDAQ · IndustrialsBruker Corp (BRKRP)
Bruker Corp brought in $3.5B of revenue over the twelve months to June 30, 2026, up 1.6% from a year earlier. It posted a net loss of $71.2M. Operating cash flow minus capital spending left $43.3M of free cash flow in fiscal 2025. At June 30, 2026 it held $184.9M in cash against $1.8B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
What Bruker Corp does
Bruker designs, manufactures, and distributes scientific instruments and analytical diagnostic solutions. Its core products include mass spectrometers, nuclear magnetic resonance systems, X-ray equipment, and microscopes. Its customers include academic research institutions, pharmaceutical companies, biotechnology laboratories, and industrial materials testing centers. Its shares trade on NASDAQ under the ticker BRKRP.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.4B | -$8.6M | -$0.15 | $43.3M |
| 2024 | $3.4B | $113.1M | $0.76 | $136M |
| 2023 | $3B | $427.2M | $2.90 | $243.2M |
| 2022 | $2.5B | $296.6M | $1.99 | $145.2M |
| 2021 | $2.4B | $277.1M | $1.81 | $190.4M |
| 2020 | $2B | $157.8M | $1.02 | $235M |
Where BRKRP ranks in Industrials
Dividends
It paid out $22.8M in cash dividends.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $22.8M | n/a |
| 2024 | $0.20 | $30.2M | 27% |
| 2023 | $0.20 | $29.4M | 7% |
| 2022 | $0.16 | $29.8M | 10% |
| 2021 | $0.16 | $24.2M | 9% |
| 2020 | $0.16 | $24.6M | 16% |
Latest SEC filings
What Bruker Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Other event 8-K
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026
- August 4, 2026
- July 30, 2026Other event 8-K
- June 12, 2026
- May 29, 2026
- May 29, 2026Shareholder vote results 8-K/A
- May 21, 2026
- May 15, 2026Other event 8-K
What is BRKRP worth? A DCF from its reported cash flow
Insider trades
What the people running Bruker Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $105.7K worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 15, 2026 | Munch MarkEXEC VP&PRES BRUKER NANO INC. | Exercised options | 2,000 | $44.4K |
| September 15, 2026 | Munch MarkEXEC VP&PRES BRUKER NANO INC. | Soldpre-planned (10b5-1) | 2,000 | $105.7K |
Questions about BRKRP
What does Bruker Corp do?
Bruker designs, manufactures, and distributes scientific instruments and analytical diagnostic solutions. Its core products include mass spectrometers, nuclear magnetic resonance systems, X-ray equipment, and microscopes. Its customers include academic research institutions, pharmaceutical companies, biotechnology laboratories, and industrial materials testing centers. Its shares trade on NASDAQ under the ticker BRKRP.
Is Bruker Corp profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $71.2M on revenue of $3.5B.
How much revenue does Bruker Corp make?
Over the twelve months to June 30, 2026 Bruker Corp reported revenue of $3.5B. That is 1.6% more than a year earlier.
When did Bruker Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 16, 2026.
Similar companies
Compare BRKRP with
Compare BRKRP with any company
Follow BRKRP
Get an email when Bruker Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow BRKRP: get an email when it filesWhere the numbers come from
Financial figures are the values Bruker Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.